Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan E Henry

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMC Biotechnology|March 28, 2009
Accumulation and processing of a recombinant protein designed as a cleavable fusion to the endogenous Rubisco LSU protein in Chlamydomonas chloroplastMachiko Muto, Ryan E Henry, Stephen P Mayfield
The EMBO Journal|January 17, 2012
A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAXRyan E Henry, Zdenek Andrysik, Ramiro París, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2008
Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activationRamiro París, Ryan E Henry, Sarah J Stephens, et al.
Genome Research|June 12, 2012
CBX3 regulates efficient RNA processing genome-wideAndrea Smallwood, Gary C Hon, Fulai Jin, et al.
Biochimica Et Biophysica Acta|February 16, 2012
The p53 circuit boardKelly D Sullivan, Corrie L Gallant-Behm, Ryan E Henry, et al.
Biotechnology and Bioengineering|May 31, 2013
Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partnersMiller Tran, Ryan E Henry, David Siefker, et al.
Nature Chemical Biology|June 5, 2012
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53Kelly D Sullivan, Nuria Padilla-Just, Ryan E Henry, et al.
Oncotarget|July 30, 2016
Acquired savolitinib resistance in non-small cell lung cancer arises via multiple mechanisms that converge on MET-independent mTOR and MYC activationRyan E Henry, Evan R Barry, Lillian Castriotta, et al.
Cell|February 10, 2010
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alphaLei Zhong, Agustina D'Urso, Debra Toiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient-Derived Xenograft ModelsAlwin G Schuller, Evan R Barry, Rhys D O Jones, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Biotechnology|March 28, 2009
Accumulation and processing of a recombinant protein designed as a cleavable fusion to the endogenous Rubisco LSU protein in Chlamydomonas chloroplastMachiko Muto, Ryan E Henry, Stephen P Mayfield
The EMBO Journal|January 17, 2012
A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAXRyan E Henry, Zdenek Andrysik, Ramiro París, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2008
Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activationRamiro París, Ryan E Henry, Sarah J Stephens, et al.
Genome Research|June 12, 2012
CBX3 regulates efficient RNA processing genome-wideAndrea Smallwood, Gary C Hon, Fulai Jin, et al.
Biochimica Et Biophysica Acta|February 16, 2012
The p53 circuit boardKelly D Sullivan, Corrie L Gallant-Behm, Ryan E Henry, et al.
Biotechnology and Bioengineering|May 31, 2013
Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partnersMiller Tran, Ryan E Henry, David Siefker, et al.
Nature Chemical Biology|June 5, 2012
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53Kelly D Sullivan, Nuria Padilla-Just, Ryan E Henry, et al.
Oncotarget|July 30, 2016
Acquired savolitinib resistance in non-small cell lung cancer arises via multiple mechanisms that converge on MET-independent mTOR and MYC activationRyan E Henry, Evan R Barry, Lillian Castriotta, et al.
Cell|February 10, 2010
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alphaLei Zhong, Agustina D'Urso, Debra Toiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient-Derived Xenograft ModelsAlwin G Schuller, Evan R Barry, Rhys D O Jones, et al.
Pageof 1